Market structure: consolidating around an integrated leader

Post-merger, mWell–KonsultaMD anchors the market at 5.8m users [BWorld 2025], backed by Metro Pacific's hospital network. Concentration is rising, with a specialist tier defending corporate and fulfilment niches rather than contesting the consumer front door head-on.

Registered-user share · 2025
% of leading-platform users · est.
mWell+Konsulta ~72% Medgate ~12% HealthNow ~9% SeeYouDoc ~4% Others ~3%
SOURCE: BWORLD 2025, PLATFORM READS, KIRA TRIANGULATION · KIRA RESEARCH 2026

A consolidating front door

The merged leader holds an estimated ~70%+ of leading-platform registered users [Kira estimates], anchored by 5.8m combined subscribers [BWorld 2025] and Metro Pacific's hospital and clinic footprint.

The remaining tier specializes: Medgate on corporate and HMO channels, HealthNow on consult-to-delivery — competing on niche economics, not raw user scale.

Merged user base5.8m
mWell pre-deal3.1m
KonsultaMD pre-deal2.7m
Deal closedFeb 2025
MARKET LEADER
RANK 01
mWell
Metro Pacific Health Tech (MPIC)
Users3.1m+
Merged5.8m
Hospital netYes
Integrated stack — Health ID, hospitals, labs, wearables; now owns KonsultaMD.
RANK 02
KonsultaMD
917Ventures / Globe → MPIC
Users2.7m
Founded2015
DoctorsWide net
Trusted brand; Globe distribution roots, retained post-merger.
RANK 03
Medgate
Medgate Philippines Inc.
FocusCorp/HMO
Model24/7
ChannelB2B2C
Corporate-health depth; employer and HMO program specialist.
RANK 04
HealthNow
HealthNow Philippines Inc.
FocusConsult+Rx
ModelDelivery
EdgeFulfilment
Consult-to-delivery — medicine fulfilment tightly coupled to the consult.
SOURCE KEY · BWorld 2025 = BusinessWorld "mWell acquires KonsultaMD" Feb 2025 · Medgate 2024 = Medgate Philippines corporate-health release 2024 · Kira estimates = KIRA in-house analyst triangulation · Share figures = KIRA estimate from platform user reads